Stock
Ownership of a fraction of a corporation and the right to claim a share of the corporation's assets and profits equal to the amount of stock owned
US listed securityListed on NASDAQ
US headquarteredHeadquartered in Gaithersburg, Maryland, United States
Follow
Novavax, Inc.
$158.10
NVAX
After Hours:(-1.33%)-$2.10
$156.00
Closed: Mar 4, 7:59:48 PM GMT-5 · USD · NASDAQ · Disclaimer
In the news
Financial performance
| (USD) | Q4 2020 | Year/year change |
|---|---|---|
Revenue | 279.66M | 3,072.18% |
Net income | -177.56M | -457.85% |
| Diluted EPS | -2.70 | -138.94% |
| Net profit margin | -63.49% | 82.42% |
| Operating income | -370.05M | -1,189.13% |
| Net change in cash | 247.00M | 3,852.03% |
| Cash on hand | 553.40M | 602.08% |
| Cost of revenue | 588.39M | 1,905.43% |
About
Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it had an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19. Wikipedia
Founded
1987
Website
Employees
792
Key stats
Previous close
The last closing price
$183.61
Day range
The difference between the high and low prices over the past day
$147.39 - $188.71
Year range
The difference between the high and low prices over the past 52 weeks
$6.77 - $331.68
Market cap
A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.
11.68B USD
Volume
The average number of shares traded each day over the past 30 days
5.34M
P/E ratio
The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks
-
Dividend yield
The ratio of annual dividend to current share price that estimates the dividend return of a stock
-
Primary exchange
Listed exchange for this security
NASDAQ
About
Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it had an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine for prevention of COVID-19. Wikipedia
Founded
1987
Website
Employees
792
